Acro Biomedical Co annual ebitda
2022
2023
2024
2025
Acro Biomedical Co EBITDA Growth & History (ACBM)
Acro Biomedical Co's calculated EBITDA was −$91,992 for fiscal 2025.
View full Acro Biomedical Co company overviewAcro Biomedical Co annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$91,992 | −$54,034 | — |
| 2024 | 2024-12-31 | −$37,958 | $8.8M | — |
| 2023 | 2023-12-31 | −$8.8M | $7.1M | — |
| 2022 | 2022-12-31 | −$15.9M | — | — |
Acro Biomedical Co quarterly ebitda
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$17,554 | −$3,940 | — |
| Q1 2026 | 2026-03-31 | −$40,271 | −$31,337 | — |
| Q4 2025 | 2025-12-31 | $45,655 | — | — |
| Q3 2025 | 2025-09-30 | −$115,099 | — | — |
| Q2 2025 | 2025-06-30 | −$13,614 | — | — |
| Q1 2025 | 2025-03-31 | −$8,934 | — | — |
Acro Biomedical Co ebitda trends
Between the periods ended 2022-12-31 and 2025-12-31, Acro Biomedical Co's ebitda increased from −$15.9M to −$91,992, a change of $15.8M. The latest reported quarter, Q2 2026, shows −$17,554.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Acro Biomedical Co source filings ↗